JOP20180070B1 - Inhibitors of receptor?interacting protein kinase 1 - Google Patents

Inhibitors of receptor?interacting protein kinase 1

Info

Publication number
JOP20180070B1
JOP20180070B1 JOP/2018/0070A JOP20180070A JOP20180070B1 JO P20180070 B1 JOP20180070 B1 JO P20180070B1 JO P20180070 A JOP20180070 A JO P20180070A JO P20180070 B1 JOP20180070 B1 JO P20180070B1
Authority
JO
Jordan
Prior art keywords
inhibitors
receptor
protein kinase
interacting protein
compositions
Prior art date
Application number
JOP/2018/0070A
Other languages
Arabic (ar)
Inventor
Anthony A Estrada
Jianwen A Feng
Brian Fox
Colin Philip Leslie
Joseph P Lyssikatos
Alfonso Pozzan
Zachary K Sweeny
Vincente Fidalgo Javier De
Original Assignee
Denali Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Denali Therapeutics Inc filed Critical Denali Therapeutics Inc
Priority to JOP/2018/0070A priority Critical patent/JOP20180070B1/en
Publication of JOP20180070A1 publication Critical patent/JOP20180070A1/en
Application granted granted Critical
Publication of JOP20180070B1 publication Critical patent/JOP20180070B1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present disclosure relates generally to compounds and compositions, and their use as kinase inhibitors.
JOP/2018/0070A 2018-07-18 2018-07-18 Inhibitors of receptor?interacting protein kinase 1 JOP20180070B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JOP/2018/0070A JOP20180070B1 (en) 2018-07-18 2018-07-18 Inhibitors of receptor?interacting protein kinase 1

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JOP/2018/0070A JOP20180070B1 (en) 2018-07-18 2018-07-18 Inhibitors of receptor?interacting protein kinase 1

Publications (2)

Publication Number Publication Date
JOP20180070A1 JOP20180070A1 (en) 2020-01-18
JOP20180070B1 true JOP20180070B1 (en) 2022-09-15

Family

ID=75469089

Family Applications (1)

Application Number Title Priority Date Filing Date
JOP/2018/0070A JOP20180070B1 (en) 2018-07-18 2018-07-18 Inhibitors of receptor?interacting protein kinase 1

Country Status (1)

Country Link
JO (1) JOP20180070B1 (en)

Also Published As

Publication number Publication date
JOP20180070A1 (en) 2020-01-18

Similar Documents

Publication Publication Date Title
TN2018000276A1 (en) Inhibitors of receptor-interacting protein kinase 1.
ZA201906822B (en) Indole ahr inhibitors and uses thereof
MX2021014441A (en) Tead inhibitors and uses thereof.
MX2021014443A (en) Tead inhibitors and uses thereof.
MX2022002877A (en) Hpk1 antagonists and uses thereof.
MX2023008031A (en) Gcn2 inhibitors and uses thereof.
MX2021004245A (en) Indole ahr inhibitors and uses thereof.
GEP20207147B (en) Substituted 3-azabicyclo[3.1.0]hexanes as ketohexokinase inhibitors
MX2022010755A (en) Kinase inhibitors and uses thereof.
MX2019001096A (en) Tlr7/8 antagonists and uses thereof.
MX2020007799A (en) Gcn2 inhibitors and uses thereof.
EP4248968A3 (en) Tlr7/8 antagonists and uses thereof
MY179781A (en) Biaryl inhibitors of bruton's tyrosine kinase
MX2016015565A (en) Certain protein kinase inhibitors.
MX2019015744A (en) Pharmaceutical compositions.
MX2020009234A (en) Heteroaryl compounds as type ii irak inhibitors and uses hereof.
MX2020006612A (en) Compound functioning as bromodomain protein inhibitor, and composition.
MX2020001793A (en) Ahr inhibitors and uses thereof.
MX2018007075A (en) Polycyclic compounds as inhibitors of bruton's tyrosine kinase.
MX2018007084A (en) Inhibitors of bruton's tyrosine kinase and methods of their use.
MX2020002123A (en) Ribociclib salts and solid state forms thereof.
PH12020550703A1 (en) Sulfonamide compounds and use thereof
ZA202309446B (en) Rapamycin analogs and uses thereof
MX2020006596A (en) Hydroxyisoxazolines and derivatives thereof.
MX2021001471A (en) Substituted benzimidazoles as pad4 inhibitors.